[144] IonQ, Inc. SEC Filing

Rhea-AI Filing Summary

IonQ Form 144 filing summary
The filing notifies a proposed sale of 8,773 shares of IonQ common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $412,769.65. The shares represent a portion of the issuer's reported 296,837,796 outstanding shares. The filer acquired the shares on 09/12/2025 by exercising stock options and paid cash on the same date. The filer reports no securities sold in the past three months for the account. The notice includes the standard representation that the selling person is not aware of undisclosed material adverse information.

Positive

• Clear compliance with Rule 144 disclosure requirements for the proposed sale
• No prior sales in past three months reported for the selling account, suggesting this is an isolated transaction

Negative

• Limited contextual information provided about the seller's relationship to IonQ or any trading plan adoption date
• Filing does not identify whether the sale is part of a wider disposition schedule, reducing transparency for investors

Insights

Securities Analyst

TL;DR: Insider plans to sell 8,773 shares acquired by option exercise; modest relative size versus outstanding shares.

The filing discloses a routine Rule 144 notice for shares acquired by exercise of stock options on 09/12/2025 and intended to be sold via Morgan Stanley Smith Barney. The transaction size (8,773 shares, $412,770 aggregate) is immaterial relative to the issuer's reported outstanding share count of 296,837,796, indicating limited direct dilution or supply impact. The filer states no sales in the prior three months, which suggests this is an isolated planned disposition rather than part of a larger accelerated sell-down. Documentation appears limited to required disclosure fields; no additional contextual detail about the selling person's role or reason for sale is provided in the filing.

Corporate Governance Expert

TL;DR: Routine compliance filing; includes standard attestation about material nonpublic information.

The Form 144 is procedural and contains the typical attestation that the seller is not aware of undisclosed material adverse information. The record shows acquisition and intended sale on the same date (09/12/2025), consistent with an option exercise followed by a planned disposition. The filing does not identify the specific insider relationship or trading plan dates, and it reports Nothing to Report for sales in the past three months, limiting assessment of trading patterns or governance implications. From a governance perspective, the form meets Rule 144 notice requirements but lacks additional context about insider status or a 10b5-1 plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8773	412769.65	296837796	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/12/2025	Exercise of Stock Options	Issuer			8773	09/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IonQ's Form 144 filed on 09/12/2025 disclose?

The filing discloses a proposed sale of 8,773 common shares through Morgan Stanley Smith Barney on the NYSE, aggregate value $412,769.65.

How were the 8,773 IonQ shares acquired?

The shares were acquired on 09/12/2025 by exercise of stock options from the issuer, with payment in cash on that date.

Does the filing report recent sales by the same person?

The filing states "Nothing to Report" for securities sold during the past three months for the account.

What is the reported number of IonQ shares outstanding in the filing?

The filing reports 296,837,796 shares outstanding.

Which broker is handling the proposed sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004.